Onset and progression of the Anderson-Fabry disease related cardiomyopathy

Christoph Kampmann1, Ales Linhart, Frank Baehner

  • 1University Children's Hospital Mainz, Germany.

Insights

Cardiac involvement in Anderson-Fabry disease (AFD) leads to significant health issues. This study found left ventricular hypertrophy (LVH) is common in both males and females with AFD, but onset is later and progression slower in females.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Cardiac involvement is a major cause of morbidity and mortality in Anderson-Fabry disease (AFD).
  • Understanding the onset and progression of cardiac issues in AFD is crucial for patient management.
  • This study focuses on documenting cardiac changes in a cohort of AFD patients.

Purpose of the Study:

  • To document the onset and progression of cardiac involvement in male and female Anderson-Fabry disease patients.
  • To analyze the correlation between age and left ventricular mass indexed (LVMi) in AFD.
  • To compare the prevalence and progression rates of left ventricular hypertrophy (LVH) between genders.

Main Methods:

  • Cross-sectional echocardiographic study of 177 male and female AFD patients.
  • Longitudinal follow-up of 76 patients (38 males, 38 females) over a mean of 4.5 years without enzyme replacement therapy.
  • Analysis of left ventricular mass indexed (LVMi) and prevalence of left ventricular hypertrophy (LVH).

Main Results:

  • A significant correlation between age and LVMi was observed in both males and females with AFD (P<0.0001).
  • Initial LVH prevalence was 48.6% in males and 36.4% in females, peaking at ages 40 and 60, respectively.
  • LVMi increased annually by 4.07 g/m(2.7) in males and 2.31 g/m(2.7) in females (P<0.01).

Conclusions:

  • Anderson-Fabry disease is associated with a high prevalence of left ventricular hypertrophy in both genders.
  • The onset of LVH in AFD is delayed in females compared to males.
  • The rate of LVH progression is slower in females with AFD.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...